a vaccine for swine flu , also known as the H1N1 virus , the company said . It is now on track to meet the orders placed by many governments and the World Health Organization for the vaccine , Glaxo said . `` To date we have contracts in place to supply 195 million doses of the vaccine , '' Chief Executive Andrew Witty said . `` We also have a variety of agreements in place with the U.S. government to supply pandemic products worth $ 250 million . Discussions with over 50 governments are ongoing , with many at advanced stages , and I therefore expect further significant orders . Shipments are expected in the second half of 2009 and early 2010 . '' In an interview with CNN 's Richard Quest , Witty said the new swine flu vaccine will likely be a boost to sales into 2010 . `` As we go forward , I think we 'll see -LRB- swine flu -RRB- become more material for the company , particularly as we move into -LRB- the fourth quarter -RRB- of this year and vaccine shipments begin , '' he said . However , he thinks any
LONDON , England -LRB- CNN -RRB- -- Sales of the flu drug Relenza shot up 1,900 percent from a year ago as governments around the world stockpiled in preparation for a swine flu pandemic , drugmaker GlaxoSmithKline said Wednesday . Stocks of antiviral treatments are pictured at a warehouse in an undisclosed location in the UK Relenza sales were # 60 million -LRB- $ 98.4 million -RRB- in the second quarter of this year , compared to # 3 million -LRB- $ 4.9 million -RRB- in the same quarter last year , the company said in announcing its Q2 results . Glaxo also said that by the end of the year , it expects to have an annual production capacity for Relenza of 190 million treatment courses , more than a threefold increase to its previously announced maximum capacity . The company will achieve it by increasing production of the Relenza Diskhaler inhaler and building new capacity to manufacture Relenza Rotacaps , Glaxo said . Watch as swine flu boosts drug profits '' Relenza is an antiviral medication similar to Tamiflu that treats symptoms of the flu and helps to prevent getting it . GlaxoSmithKline started production last month of